These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26518939)

  • 21. A role for complement in the rejection of porcine ventral mesencephalic xenografts in a rat model of Parkinson's disease.
    Barker RA; Ratcliffe E; McLaughlin M; Richards A; Dunnett SB
    J Neurosci; 2000 May; 20(9):3415-24. PubMed ID: 10777804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune responses to alpha1,3 galactosyltransferase knockout pigs.
    Puga Yung G; Schneider MK; Seebach JD
    Curr Opin Organ Transplant; 2009 Apr; 14(2):154-60. PubMed ID: 19300259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural anti-galactose alpha1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts.
    Raeder RH; Badylak SF; Sheehan C; Kallakury B; Metzger DW
    Transpl Immunol; 2002 Jun; 10(1):15-24. PubMed ID: 12182460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of Gal-alpha1,3Gal epitope on xenogeneic lines: implications for cellular gene therapy based on the encapsulation technology.
    Déglon N; Aubert V; Spertini F; Winkel L; Aebischer P
    Xenotransplantation; 2003 May; 10(3):204-13. PubMed ID: 12694540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-non-Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF-transgenic porcine hearts in cynomolgus monkeys.
    Lam TT; Paniagua R; Shivaram G; Schuurman HJ; Borie DC; Morris RE
    Xenotransplantation; 2004 Nov; 11(6):531-5. PubMed ID: 15479463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection.
    Ohdan H; Yang YG; Shimizu A; Swenson KG; Sykes M
    J Clin Invest; 1999 Aug; 104(3):281-90. PubMed ID: 10430609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravital microscopic investigation of xenogeneic microcirculation and impact of complement depletion by cobra venom factor.
    Diefenbeck M; Linke R; Seehofer D; Terajima H; Thiery J; Hammer C
    Xenotransplantation; 1998 Nov; 5(4):262-73. PubMed ID: 9915254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival.
    Candinas D; Lesnikoski BA; Robson SC; Miyatake T; Scesney SM; Marsh HC; Ryan US; Dalmasso AP; Hancock WW; Bach FH
    Transplantation; 1996 Aug; 62(3):336-42. PubMed ID: 8779679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune response to bovine pericardium implanted into α1,3-galactosyltransferase knockout mice: feasibility as an animal model for testing efficacy of anticalcification treatments of xenografts.
    Lee C; Ahn H; Kim SH; Choi SY; Kim YJ
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):164-72. PubMed ID: 22223697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allosensitization does not increase the risk of xenoreactivity to alpha1,3-galactosyltransferase gene-knockout miniature swine in patients on transplantation waiting lists.
    Wong BS; Yamada K; Okumi M; Weiner J; O'Malley PE; Tseng YL; Dor FJ; Cooper DK; Saidman SL; Griesemer A; Sachs DH
    Transplantation; 2006 Aug; 82(3):314-9. PubMed ID: 16906027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Administration of GAS914 in an orthotopic pig-to-baboon heart transplantation model.
    Brandl U; Michel S; Erhardt M; Brenner P; Bittmann I; Rössle M; Baschnegger H; Bauer A; Hammer C; Schmoeckel M; Reichart B
    Xenotransplantation; 2005 Mar; 12(2):134-41. PubMed ID: 15693844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined transgenic expression of alpha-galactosidase and alpha1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galalpha(1,3)Gal.
    Osman N; McKenzie IF; Ostenried K; Ioannou YA; Desnick RJ; Sandrin MS
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14677-82. PubMed ID: 9405672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-treatment of donor with 1-deamino-8-d-arginine vasopressin could alleviate early failure of porcine xenograft in a cobra venom factor treated canine recipient.
    Kang HJ; Lee G; Kim JY; Lee SH; Wi HC; Hwang PG; Chung DH; Kim YT
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):149-56. PubMed ID: 15982598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts.
    Lam TT; Hausen B; Hook L; Lau M; Higgins J; Christians U; Jacobsen W; Baluom M; Duthaler R; Katopodis A; Chavez G; Cozzi E; Harrison R; Schuurman HJ; Borie D; Morris RE
    Xenotransplantation; 2005 Jan; 12(1):20-9. PubMed ID: 15598270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cobra venom factor stimulates anti-alpha-galactose antibody production in baboons. Implications for pig-to-human xenotransplantation.
    Taniguchi S; Kobayashi T; Neethling FA; Ye Y; Niekrasz M; White DJ; Cooper DK
    Transplantation; 1996 Sep; 62(5):678-81. PubMed ID: 8830836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of cartilage from H-transferase transgenic pigs.
    Costa C; Brokaw JL; Fodor WL
    Transplant Proc; 2008 Mar; 40(2):554-6. PubMed ID: 18374127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fucosyl transferase (H) transgenic heart transplants to Gal-/- mice.
    McKenzie IF; Li YQ; Patton K; Sandrin MS
    Transplantation; 2000 Oct; 70(8):1205-9. PubMed ID: 11063342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic suppression of pre-perfusion of donor livers with recipient serum and cobra venom factor treatment on hyperacute rejection following liver xenotransplantation.
    Zhu B; Tong C; Guo W; Pu R; Zhang G; Wang L; Li M
    Acta Cir Bras; 2012 May; 27(5):301-5. PubMed ID: 22666742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The xenoantibody response and immunoglobulin gene expression profile of cynomolgus monkeys transplanted with hDAF-transgenic porcine hearts.
    Zahorsky-Reeves JL; Kearns-Jonker MK; Lam TT; Jackson JR; Morris RE; Starnes VA; Cramer DV
    Xenotransplantation; 2007 Mar; 14(2):135-44. PubMed ID: 17381688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of antibody synthesis and complement activation in concordant xenograft retransplantation.
    Gannedahl G; Karlsson-Parra A; Wallgren A; Roos-Engstrand E; Nilsson B; Tötterman TH; Tufveson G
    Transplantation; 1994 Aug; 58(3):337-44. PubMed ID: 8053058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.